Mobile Site ›

Test Catalog

Test ID: AGXT    
Alanine:Glyoxylate Aminotransferase (AGXT) Mutation Analysis (G170R), Blood

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Useful For Suggests clinical disorders or settings where the test may be helpful

Identifying patients with the pyridoxine responsive form of PH1


Determining the presence of the Gly170Arg (G170R) mutation in the AGXT gene


Carrier testing of at-risk family members

Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request

Detects Gly170Arg mutation associated with assessment of pyridoxine responsiveness only. This test is not diagnostic for hyperoxaluria type I.

Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Direct Mutation Analysis by Polymerase Chain Reaction (PCR)

(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

AGXT Mutation Analysis (G170R)

Aliases Lists additional common names for a test, as an aid in searching

PH1 (Primary Hyperoxaluria Type 1)